Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Modern Rheumatology|August 5, 2024
Risk factors for adverse drug reactions to sulfamethoxazole-trimethoprim prophylaxis in patients with rheumatic and musculoskeletal diseasesKazuoto Hiramoto, Mitsuhiro Akiyama, Yuko Kaneko
Respirology Case Reports|May 1, 2026
Seropositive Rheumatoid Arthritis Emerging During Acute Phase of Lung Abscess: A Case ReportYusuke Arai, Hiromu Tanaka, Kazuoto Hiramoto, et al.
Clinical Kidney Journal|June 27, 2022
Decreased chronic kidney disease in rheumatoid arthritis in the era of biologic disease-modifying anti-rheumatic drugsHironari Hanaoka, Jun Kikuchi, Kazuoto Hiramoto, et al.
Clinical and Experimental Rheumatology|January 9, 2023
Deep remission within 12 months prevents renal flare and damage accrual in lupus nephritisJun Kikuchi, Hironari Hanaoka, Shuntaro Saito, et al.
Rheumatology (Oxford, England)|January 11, 2022
Lupus low disease activity state within 12 months is associated with favourable outcomes in severely active systemic lupus erythematosusJun Kikuchi, Hironari Hanaoka, Shuntaro Saito, et al.
International Journal of Rheumatic Diseases|August 4, 2023
Sarcopenia in patients with rheumatic musculoskeletal diseasesHironari Hanaoka, Jun Kikuchi, Kazuoto Hiramoto, et al.
Modern Rheumatology|October 14, 2024
Dapagliflozin for rheumatic musculoskeletal disease in patients with chronic kidney diseaseHironari Hanaoka, Jun Kikuchi, Kazuoto Hiramoto, et al.
Modern Rheumatology|December 26, 2025
Impact of deep remission on renal flare in pure class V lupus nephritis: results from KEIO-SLE cohort, a retrospective cohort studyMasatoshi Kawai, Hironari Hanaoka, Hiroyuki Fukui, et al.
Modern Rheumatology Case Reports|February 28, 2026
Effectiveness of tocilizumab for IgA vasculitis associated with idiopathic multicentric Castleman's disease: two cases and literature reviewKoji Suzuki, Koichi Saito, Mitsuhiro Akiyama, et al.
International Journal of Rheumatic Diseases|October 9, 2021
Early combination of pulmonary vasodilators prevents chronic kidney disease progression in connective tissue disease-associated pulmonary hypertensionHironari Hanaoka, Sho Ishigaki, Hiroshi Takei, et al.
Pageof 2